Pharmacological characterization of oxime agonists of the histamine H 4 receptor

Journal of Receptor, Ligand and Channel Research

Volumn 3, Issue , 2010, Pages 37-49

  Yu, Fuqu ^a   Wolin, Ronald L ^a   Wei, Jianmei ^a   Desai, Pragnya J ^a   McGovern, Patricia M ^a   Dunford, Paul J ^a   Karlsson, Lars ^a   Thurmond, Robin L ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Eosinophils; H4 receptor; Mast cells; Pruritus

Indexed keywords

1 (5 CHLORO 2 BENZIMIDAZOLYLCARBONYL) 4 METHYLPIPERAZINE; 1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; CALCIUM; HISTAMINE AGONIST; HISTAMINE H4 RECEPTOR; INDOLE; JNJ 28610244; OXIME DERIVATIVE; POTASSIUM; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL SHAPE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; EOSINOPHIL; GUINEA PIG; HUMAN; HUMAN CELL; MAST CELL; MONKEY; MOUSE; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PROTEIN FUNCTION; PROTEIN TARGETING; RAT; SCRATCHING; STRUCTURE ACTIVITY RELATION;

CANIS FAMILIARIS; CAVIA; MUS; RATTUS;

EID: 77952784170     PISSN: None     EISSN: 1178699X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov. 2008;7(1):41-53.
2. Edwards MP, Doherty AM, Ley SV, Organ HM. Preparation of 2-substituted pyrroles and indoles by regioselective alkylation and deprotection of 1-(2-trimethylsilylethoxymethyl)pyrrole and 1-(2-trim ethylsilylethoxymethyl) indole. Tetrahedron. 1986;42(13):3723-3729.
3. Zhang D, Kohlman D, Krushinski J, et al. Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists. Bioorg Med Chem Lett. 2004;14(24):6011-6016.
4. Cain GA, Teleha CA. A convenient synthesis of N-Boc-4-formylpiperidine. Org Prep Proced Int. 2000;32(1):96-99.
5. Nahm S, Weinreb SM. N-Methoxy-N-methylamides as effective acylating agents. Tetrahedron Lett. 1981;22(39):3815-3818.
6. Clarke HT, Gillespie HB, Weisshaus SZ. Action of formaldehyde on amines and amino acids. J Am Chem Soc. 1933;55:4571-4587.
7. Moore ML. Leuckart reaction. Org Reactions. 1949;5:301-330.
8. Phinney KW. Enantioselective separations by packed column subcritical and supercritical fluid chromatography. Anal Bioanal Chem. 2005;382(3):639-645.
9. Hawkes GE, Herwig K, Roberts JD. Nuclear magnetic resonance spectroscopy. Use of carbon-13 spectra to establish configurations of oximes. J Org Chem. 1974;39(8):1017-1028.
10. Saulnier MG, Gribble GW. Generation and reactions of 3-lithio-1- (phenylsulfonyl)indole. J Org Chem. 1982;47(5):757-761.
11. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther. 2003;305(3):1212-1221.
12. Jablonowski JA, Grice CA, Chai W, et al. The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem. 2003;46(19):3957-3960. (Pubitemid 37122442)
13. 4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther. 2004;309(1):404-413.
14. 4 receptor. Eur J Pharmacol. 2008;592(1-3):26-32.
15. 4) expressed in bone marrow. Mol Pharmacol. 2001;59(3):420-426.
16. 4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther. 2001;299(1):121-130.
17. Leurs R, Smit MJ, Menge WM, Timmerman H. Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells. Br J Pharmacol. 1994;112(3):847-854.
18. Cheng YC, Prusoff WH. Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction. Biochem Pharmacol. 1973;22(23):3099-3108.
19. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol. 2004;142(1):161-171.
20. 4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol. 2007;119(1):176-183.
21. 1 receptors in scratching induced by histamine receptor agonists in BalbC mice. Br J Pharmacol. 2004;142:374-380.
22. Huang JF, Thurmond R. The new biology of histamine receptors. Curr Allergy Asthma Rep. 2008;8(1):21-27.
23. Schneider E, Machavoine F, Pleau JM, et al. Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels. J Exp Med. 2005;202(3):387-393.
24. 4 receptor agonist. J Pharmacol Exp Ther. 2005;314(3):1310-1321.
25. 4 receptor agonist VUF 8430. Br J Pharmacol. 2009;157(1):34-43.
26. 4 agonism in antigen-specific human T-cell responses. Immunology. 2007;121(2):266-275.
27. Lim HD, Graaf CD, Jiang W, et al. Molecular basis of pharmacological differences among the H4R species variants. Mol Pharmacol. 2009; Submitted.
28. Kenakin T. Principles: Receptor theory in pharmacology. Trends Pharmacol Sci. 2004;25(4):186-192.
29. Sabroe I, Hartnell A, Jopling LA, et al. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol. 1999;162(5):2946-2955.
30. Venable JD, Cai H, Chai W, et al. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: Potent human histamine H4 antagonists. J Med Chem. 2005;48(26):8289-8298.